Jennifer Gander, PhD, MSPH

Dr. Jennifer Gander is a Research Investigator at the Center for Research and Evaluation (CRE). Dr. Gander’s focus is to improve health outcomes for patients, and she is committed to a career in clinical and translational research.

Dr. Jennifer Gander completed her doctoral training in epidemiology at the University of South Carolina. Dr. Gander has more than 15 years of experience working in public health ranging on community health surveillance projects, evaluating the impact of health care policies on health care access, developing multifactorial epidemiology studies, and establishing diverse longitudinal cohorts that explore complex problems. She is the lead investigator for KP Georgia for the Connect for Cancer Prevention study and serves as a transplant epidemiologist for Kaiser Permanente National Transplant Services. Dr. Gander is also an Associate Professor for the Kaiser Permanente Bernard J. Tyson School of Medicine.

Publications: NCBI Collections

Selected Research:

Connect for Cancer Prevention Study (CONNECT)

This project is a collaboration of 4 Kaiser Permanente (KP) regions (Colorado, Georgia, Hawaii, and Northwest) and 6 additional sites participating in the assembly of a prospective multi-center cohort study that will include up to 200,000 cancer-free adults 40 through 65 years old. This cohort will serve an invaluable function in the conduct of research into cancer etiology and prevention.

Funder: National Cancer Institute
End Date: 11/03/2028

Prevalence and natural history of patients with non-malignant adrenal tumors and autonomous cortisol secretion (ACS)

The project will establish a retrospective cohort to provide an estimate of the incidence and prevalence of ACS from an adrenal nodule and of ACS comorbidities in the general population.

Funder: Sparrow Pharmaceuticals
End Date: 05/31/2024

Risk of new-onset diabetes following COVID-19: a multiethnic cohort study of 1 million+ individuals across the life course

The goal of the multi-site project will be to create a combined cohort of adults, pregnant adults, and children to understand the risk of diabetes incidence in the various populations. CRE will serve as the data coordinating center.

Funder: National Institute of Diabetes and Digestive and Kidney Diseases
End Date: 07/31/2024

Researching COVID to Enhance Recovery (RECOVER): Adult cohort

CRE is one of >80 national sites participating in the RECOVERY Initiative to establish an adult cohort to better understand SARS-CoV-2 infection and follow up. We aim to characterize the incidence and prevalence of post-acute sequelae of SARS-CoV-2, characterize the clinical course and recovery of sequelae over time, and define the pathophysiology of and mechanisms of post-acute sequelae, including direct and indirect causal effects of COVID-19 infection, and potential modifiers (e.g., sex, age, and race/ethnicity).

Funder: National Institute of Health
End Date: 12/31/2028